Immunological algorithms in EMAS

Negative selection algorithm

Generally speaking immunological algorithms, which are based on immune system of vertebrates, are similar to evolutionary algorithms. There is also a population, which is transformed by the means of mutation. Main difference consists in introducing certain similarity measure, or similarity function and using it in order to affect the transformations of populations. As an example, negative selection algorithm will be presented, which may be used to detect and remove intruders (appropriately defined) from the system. Pseudo code of this algorithm is as follows:

  1. Generate random detectors.
  2. Present self (good individuals) to the (immature) detectors, if any of the detector matches the individual (by the means of similarity function) it is removed from the system.
  3. Remaining detector are considered mature and may be used to detect non-self (bad) indviduals.

For more information about classical immunological algorithms see TW:HP2002, WIERZ2001.

Fitness computation

Computation of fitness function value is one of the most common and crucial task in evolutionary algorithms, and usually it is very simple and straightforward. E.g. considering optimization of multi-modal, multi-dimensional function, one can absolutely neglect the computation cost of the fitness function value. However, there exist number of problems, which may be solved by the means of evolution, at the same time using very complex fitness function, e.g.:

immunological Evolutionary Multi-Agent System (iEMAS)

iEMAS being the merge of evolutionary (EMAS) and immunological (negative selection inspiration) is aimed at increasing the performance of evolutionary optimization, especially when fitness computation is very time-consuming. The idea of iEMAS is based on the fact, that bad phenotypes come from bad genotypes, so there may exist an alorithm, which when appropriately applied, could remove "bad" genotypes, before even fitness is computed. Thus, the creation of "bad" phenotypes may be hindered. Following this paradigm, a new group of agents is introduced into EMAS. They play the roles of lymphocytes (or T-Cells) and remove "bad" agents from the population in the following way: